Industry Reports
Lexicon Pharmaceuticals acquires exclusive rights to development candidate for Neuropathic pain from its alliance with Bristol-Myers Squibb
Lexicon Pharmaceuticals Inc announced that it has obtained exclusive research, development and commercialization rights to LX9211 (BMS-986176), a development candidate for neuropathic pain that was...
Industry Reports
Medivir strengthens its clinical pipeline by entering into agreement to acquire a portfolio of clinical stage oncology programs
Medivir AB announces that it has entered into an agreement to acquire two clinical stage oncology programs from Tetralogic Pharmaceuticals Corporation , advancing and expanding...
Industry Reports
Aralez Completes Acquisition Of Toprol-XL And Its Authorized Generic From AstraZeneca
Aralez Pharmaceuticals Inc a global specialty pharmaceutical company announced that its subsidiary, Aralez Pharmaceuticals Trading DAC (Aralez Ireland), has completed its acquisition of the U.S....
Industry Reports
IMS Health and Quintiles Transnational Holdings Merge completed
Quintiles IMS Holdings has successfully completed its merger of equals transaction between IMS Health Holdings and Quintiles Transnational Holdings. The merger of...
Industry Reports
ICU Medical to acquire the Hospira Infusion Systems Business from Pfizer for $1B
ICU Medical will acquire all of Pfizer’s global infusion therapy business, Hospira Infusion Systems (HIS), for $1 billion in cash and stock. ...
Industry Reports
PAREXEL Announces Execution of Definitive Agreement to Acquire ExecuPharm
PAREXEL International Corporation , a leading global biopharmaceutical services provider announced that the Company has entered into a definitive agreement to acquire ExecuPharm, Inc ,...
Industry Reports
Teva Completes Acquisition of Anda, Inc
Teva Pharmaceutical Industries Ltd announced that it has completed its acquisition of Anda, Inc., a leading distributor of generic pharmaceuticals in the U.S., from Allergan...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.